Background Chemotherapy is the standard of care for incurable advanced gastric cancer.
Whether the addition of gastrectomy to chemotherapy improves survival for patients with …

… Shuichi Hironaka, Chiba Cancer Center, Chiba; Shinya Ueda and Isamu Okamoto, Kinki
University, Osakasayama; Hirofumi Yasui, Shizuoka Cancer Center, Shizuoka; Tomohiro …

Background Trifluridine/tipiracil showed activity and was well tolerated in a phase 2 study of
pretreated patients with advanced gastric cancer done in Japan. We investigated whether …

Objective: To clarify the role of splenectomy in total gastrectomy for proximal gastric cancer.
Backgrounds: Splenectomy in total gastrectomy is associated with increased operative …

Background Malnutrition is an independent risk factor for postoperative mortality and morbidity
in major gastrointestinal surgery. The aim of this study was to investigate the prevalence …

Background Malignancy is a secondary cause of sarcopenia, which is associated with
impaired cancer treatment outcomes. The aim of this study was to investigate the prevalence of …

We established a preoperative exercise and nutritional support program for elderly sarcopenic
patients with gastric cancer. Twenty-two gastric cancer patients aged 65 years or older …

Background VEGF and VEGF receptor 2 (VEGFR-2)-mediated signalling and angiogenesis
can contribute to the pathogenesis and progression of gastric cancer. We aimed to assess …

Background Weekly administration of solvent-based paclitaxel is one of the standard second-line
chemotherapy regimens for advanced gastric cancer. Nanoparticle albumin-bound …

BACKGROUND & AIMS: The mechanism of plasma membrane blebbing (dissociation of the
lipid bilayer from the membrane cytoskeleton) in hepatocyte injury is not known. The aim of …